Figure S23 from Early Immune Remodeling Steers Clinical Response to First-Line Chemoimmunotherapy in Advanced Gastric Cancer

Figure S23. Heatmaps showing the number of significant inferred ligandreceptor interactions between major cell types using CellPhoneDB on scRNAseq data in (A) normal, (B) baseline tumor, (C) post-chemotherapy (FU1) tumor and (D) post-immunotherapy (FU2) tumor samples.